Abstract
Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Current Organic Chemistry
Title: The Daphniphyllum Alkaloids
Volume: 13 Issue: 6
Author(s): Mei Dong, Man-Li Zhang, Qing-Wen Shi, Yu-Cheng Gu and Hiromasa Kiyota
Affiliation:
Keywords: Daphniphyllum, alkaloids, secondary metabolites, polycyclic skeletons, organic synthesis, biosynthesis, bioactivity
Abstract: Daphniphyllum alkaloids are a growing group of secondary metabolites of great structural diversity, with complex polycyclic skeletons from Daphniphyllum plants. A large number of new Daphniphyllum alkaloids with novel frameworks have been isolated from Daphniphyllum species in the past decade. These unusual structural characteristics will attract the attention of scientists in the fields of organic synthesis, bioactivity evaluation and biosynthetic studies. This review lists all the Daphniphyllum alkaloids as well as their biosynthesis, bioactivity and synthesis reported by the end of first half of 2008.
Export Options
About this article
Cite this article as:
Dong Mei, Zhang Man-Li, Shi Qing-Wen, Gu Yu-Cheng and Kiyota Hiromasa, The Daphniphyllum Alkaloids, Current Organic Chemistry 2009; 13 (6) . https://dx.doi.org/10.2174/138527209787847345
DOI https://dx.doi.org/10.2174/138527209787847345 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
From Lab Bench to Algorithm: The Future of Organic Chemistry Powered by AI
Organic chemistry, with its intricate dance of molecules and reactions, is undergoing a transformation fuelled by the power of Artificial Intelligence (AI) and Machine Learning (ML). The integration of AI/ML with Organic Chemistry is revolutionizing the field by enhancing the efficiency and accuracy of chemical research and development. These technologies ...read more
Hybrid-Materials Catalyzed Conversion of Molecules and Substances
To address the global energy and environmental issues, and inspired by the photosynthesis of plants, scientists have material shifted their focus from traditional chemistry to novel ones to discover new substances and molecules. Hybrid materials with their unique synergistic effects, interface regulation capabilities, and functional integration have emerged as a ...read more
Natural terpenes: The Chemistry and Biological Significance
Natural organic compounds such as alkaloid, flavonoid, terpene, protein, and saccharide have been widely applied in the fields of medicine, food supplements, agriculture, cosmetics and material sciences. Terpenes as an important natural products present intensively structural diversity and widely pharmacological properties. As an important origin of medicine, the chemistry and ...read more
Porphyrazine, its Analogues and Their Metalcomplexes: Theoretical Consideration and Experimental Data
Porphyrazines are specific analogues of porphyrins – macrocyclic compounds with tetrapyrrole macrocycles, which are key components of a number of natural compounds, in particular chlorophyll and heme, playing a decisive role in the processes of reversible transfer of oxygen molecules in living organisms. They differ from porphyrins in that their ...read more
Related Journals

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
Current Pharmaceutical Design Targeting Chk2 Kinase: Molecular Interaction Maps and Therapeutic Rationale
Current Pharmaceutical Design Evaluating the Diagnostic and Chemotherapeutic Potential of Vancomycin- Derived Imaging Conjugates
Medicinal Chemistry Flavonoids and PI3K/Akt/mTOR Signaling Cascade: A Potential Crosstalk in Anticancer Treatment
Current Medicinal Chemistry MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer
Recent Patents on Biomarkers Development of Novel Therapeutic Drugs in Humans from Plant Antimicrobial Peptides
Current Protein & Peptide Science The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
Current Pharmaceutical Design Renal Cell Carcinoma in a Patient with Rheumatoid Arthritis Treated with Adalimumab
Current Drug Safety Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in COVID-19, MERS and SARS Coronaviruses
Anti-Infective Agents Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical Thioacetic Acid Addition
Current Bioactive Compounds Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy
Current Medicinal Chemistry Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets Towards the Synthesis of a Heterocyclic Analogue of Natural Cyclooligopeptide with Improved Bio-properties
Current Organic Synthesis Chemical and Genetic Engineering Strategies to Improve the Potency of Pharmaceutical Proteins and Enzymes
Current Medicinal Chemistry α-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson's Disease
CNS & Neurological Disorders - Drug Targets Peptides Against Autoimmune Neurodegeneration
Current Medicinal Chemistry Benzisothiazolone Derivatives Exhibit Cytotoxicity in Hodgkin’s Lymphoma Cells through NF-κB Inhibition and are Synergistic with Doxorubicin and Etoposide
Anti-Cancer Agents in Medicinal Chemistry Proteins of the Esterase Family: Patents for Some Proteins in Search of Metabolic Functions
Recent Patents on Biomarkers Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets
Current Cancer Drug Targets